Publications & Presentations

Nanoscope Presentations

The American Society of Retina Specialists | Annual Meeting | October 8-12, 2021
Safety and Efficacy of Intravitreal Optogenetic Gene Therapy for Advanced Retinitis Pigmentosa
Presented by Sai H. Chavala, MD

Bascom Palmer Eye  Institute | McKnight Vision Research Seminar | October 27, 2021
Ambient light activatable Multi-Characteristic Opsin Optogenetic Therapy for diseases with outer retinal degeneration
Presented by Dr. Samarendra Mohanty, Co-Founder & President, Nanoscope Therapeutics

ICRN/Choroidermia | October 27, 2021
Intravitreal AAV2-MCO Optogenetic Vision Restoration
Presented by Dr. Samarendra Mohanty, Co-Founder & President, Nanoscope Therapeutics

EURETINA 2021 Virtual | September, 2021
52 Weeks Safety and Efficacy of Multi-Characteristic Opsin Optogenetics Therapy in Patients with Inherited Retinal Degeneration
Presented by Santosh Mahapatra, MBBS, MS, JPM Rotary Eye Hospital and Research Institute, Odisha (India); Principal Investigator, MCO Study, Nanoscope Therapeutics

OIS Retina@ASRS 2021 | October 7, 2021
Pioneering New Wave of Optogenetic Therapeutics for Vision Restoration
Presented by Dr. Samarendra Mohanty, Co-Founder & President, Nanoscope Therapeutics

Eyecelerator@AAO 2021 | November 11, 2021
Pioneering New Wave of Optogenetic Therapeutics for Vision Restoration
Presented by Samarendra Mohanty, PhD, Co-Founder & President, Nanoscope Therapeutics

Nanoscope Scientific Publications

Nanoscope Therapeutics, Inc.
Trinity Towers
2777 N. Stemmons Fwy.
Dallas, TX 75207
(817) 857-1186

  • Dr. Samarendra Mohanty, PhD |  Co-Founder & President

    Samarendra Mohanty (Co-Founder/President) is an inventor & serial entrepreneur with 20+ years experience in Biomedical Sciences. He is Co-Founder of several Biotechs and Biomedical device /diagnostic companies (developed & commercialized $100K+ biomedical instruments.)

    Dr. Mohanty obtained M.Tech in Applied Optics from the Indian Institute of Technology-Delhi and a PhD in (Bio)Physics from the Indian Institute of Sciences-Bangalore.

    His extensive Biomedical Technologies experience includes serving as Professor/Senior Scientist at the University of Texas;  University of California, Irvine; Center for Adv. Tech (India); Int. Mol. Biotech (Germany); Univ. Pavia (Italy); NUS (Singapore); and University of St. Andrews (UK). He has authored over 200 international patents and publications in leading journals including Nature and Nature Photonics.

    He is the Principal Investigator for major grants from the National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs an international conference on optogenetics. He is the winner of a 2019 Healthcare Heroes award (Fort Worth Business Press), Retinal Organoid Challenge Award, Audacious Goal Initiative Award (NIH), Finalist of Tech Titan, and NIH-Director’s Innovator Award.